NCT02518048View on ClinicalTrials.gov

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Skin and Connective Tissue Diseases
Interventions
DRUG

LEO 90100 Aerosol foam

DRUG

Betesil® 2.25 mg

Trial Locations (1)

06000

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY